TECH Share Price

Open 100.05 Change Price %
High 100.26 1 Day -0.06 -0.06
Low 98.68 1 Week -3.01 -2.95
Close 99.00 1 Month -5.23 -5.02
Volume 312019 1 Year 16.85 20.51
52 Week High 117.42
52 Week Low 80.46
TECH Important Levels
Resistance 2 100.46
Resistance 1 99.86
Pivot 99.31
Support 1 98.14
Support 2 97.54
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
APRI 2.86 89.40%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
APRI 2.86 89.40%
AMCF 0.06 50.00%
LOCM 0.09 50.00%
SKBI 0.12 50.00%
UNXL 1.69 34.13%
LIFE 3.25 32.65%
CHCI 2.42 29.41%
GLBS 6.17 27.22%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
THTI 0.15 -40.00%
More..

Techne Corporation (NASDAQ: TECH)

TECH Technical Analysis 4
As on 18th Jan 2017 TECH Share Price closed @ 99.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 103.71 & Strong Sell for SHORT-TERM with Stoploss of 104.02 we also expect STOCK to react on Following IMPORTANT LEVELS.
TECH Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
TECH Other Details
Segment EQ
Market Capital 2603798528.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.techne-corp.com
TECH Address
TECH
614 McKinley Place North East
Minneapolis, MN 55413-2610
United States
Phone: 612-379-8854
Fax: 612-379-6580
Interactive Technical Analysis Chart Techne Corporation ( TECH NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Techne Corporation
TECH Business Profile
TECHNE Corporation is engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls. These activities are conducted through its wholly owned subsidiaries, Research and Diagnostic Systems, Inc. (R&D Systems), Boston Biochem, Inc. (Boston Biochem), and BiosPacific, Inc. (BiosPacific). The Company operates in two segments: biotechnology and hematology. The Company's biotechnology reporting segment develops, manufactures and sells biotechnology research and diagnostic products world-wide. The Company's hematology reporting segment, which consists of R&D Systems' Hematology Division, develops and manufactures hematology controls and calibrators for sale worldwide. In July 2013, the Company announced that it has completed the acquisition of Bionostics Holdings Limited and its operating subsidiary Bionostics, Inc. (Bionostics).